Overproduction of DYRK1A has been linked to increased tau phosphorylation and aggregation and is a likely contributor to higher incidence of AD in the Down syndrome (DS) population (Liu et al., 2008; Wegiel, Gong, & Hwang, 2011). Here, MAPT is linked to Alzheimer disease.